Phase-II study of the new aza-anthracenedione, BBR 2778, in patients with relapsed aggressive non-Hodgkinxxxs lymphomas

P Borchmann, F Morschhauser, A Parry, R Schnell, JL Harousseau, C Gisselbrecht, C Rudolph, Martin Wilhelm (Co-author), HG Derigs, M Pfreundschuh, G Camboni, A Engert

    Research output: Contribution to journalOriginal Articlepeer-review

    41 Citations (Web of Science)
    Original languageEnglish
    Pages (from-to)888-894
    JournalHAEMATOLOGICA
    Volume88
    Issue number8
    Publication statusPublished - 2003

    Keywords

    • CONTINUOUS-INFUSION
    • CELL LYMPHOMA
    • MITOXANTRONE
    • DOXORUBICIN
    • CARDIOTOXICITY
    • REGIMEN
    • TRIAL
    • AMETANTRONE
    • PACLITAXEL
    • IFOSFAMIDE

    Cite this